Profile picture

Professor Christopher B Granger

Duke University Medical Center, Durham (United States of America)
Follow
Biography
Dr. Granger is Professor of Medicine and Nursing at Duke University and at the Duke Clinical Research Institute. His primary research interests are in conduct and methodology of randomized clinical trials in heart disease and implementation research to more effectively apply proven therapies. He has co-authored over 1000 peer-reviewed manuscripts and is in the top 1% of researchers by Clarivate Analytics. He has chaired steering committees on many multicenter randomized clinical trials in acute cardiovascular care, heart failure, atrial fibrillation, and hypertension. He is past Chairman of the American Heart Association Mission: Lifeline program. He is a member of ACC/AHA guideline committees for ST-Segment Elevation M,I for the Focused Update on Duration of Dual Antiplatelet Therapy in Patients with Coronary Artery Disease, and for Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. He leads the RACE-CARS cluster randomized trial funded by the NHLBI.
Logo ESC

Contributor content

Ask the Trialists from Hot Line 6
Session
Ask the Trialists from Hot Line 6
1 September 2024
HOT LINE 7
Session
HOT LINE 7
28 August 2023
Understanding clinical trials: endpoints, statistics, and interpretation
Session
Understanding clinical trials: endpoints, statistics, and interpretation
25 August 2023
Antithrombotic therapy in ACS: hot topics 2023
Session
Antithrombotic therapy in ACS: hot topics 2023
26 March 2023
Novel treatment options for acute HF
Session
Novel treatment options for acute HF
24 March 2023
Controversies in critical care cardiology
Session
Controversies in critical care cardiology
24 March 2023
Out-of-hospital cardiac arrest: how to move the needle in outcome
Session
Out-of-hospital cardiac arrest: how to move the needle in outcome
19 March 2022
All about cardiac arrest
Session
All about cardiac arrest
18 March 2022
Atrial fibrillation in the context of acute coronary syndromes and coronary intervention: what should we do?
Session
Atrial fibrillation in the context of acute coronary syndromes and coronary intervention: what should we do?
28 August 2018
Biomarker-based approaches for improved atrial fibrillation management
Session
Biomarker-based approaches for improved atrial fibrillation management
26 August 2018

ESC 365 is supported by